Estée Lauder Awarded $15 Million for Breast Cancer Research
The grant will fund a global initiative focused on early-onset breast cancer in women under the age of 45.
Updated on Sept. 23, 2026 in Cancer
Live Poll
Should medical research funding be more heavily prioritized for younger women at risk for breast cancer?
The Estée Lauder Companies has awarded a $15 million grant to the Breast Cancer Research Foundation to launch the Global Research Initiative on Breast Cancer in Younger Women. The five-year program aims to address the rising incidence of breast cancer in younger populations.
Why it matters
Diagnoses of breast cancer among women under 45 rose 11 percent between 2012 and 2022, yet research focused on this demographic has historically been limited. Younger women are often diagnosed at later stages, where the cancer may present more aggressively.
Breast cancer diagnoses in women under 45 increased 11 percent from 2012 to 2022, though research funding focused on this group accounted for just 0.6 percent of total breast cancer funding since 2020.
The players
The Estée Lauder Companies
A multinational manufacturer of prestige skincare, makeup, fragrance, and hair care products that has funded medical research for decades.
Breast Cancer Research Foundation
A non-profit organization founded in 1993 that provides funding for breast cancer research and awareness programs globally.
The details
The grant supports a multi-year global initiative dedicated to investigating risk prediction, prevention, and early detection strategies. While breast cancer death rates have fallen 44 percent over the past three decades, tumors in younger patients often require distinct treatment approaches compared to older cohorts.
Timeline
Breast Cancer Awareness Month began in 1985.
Estée Lauder's breast cancer campaign started in 1992.
The Breast Cancer Research Foundation was established in 1993.
Diagnoses under age 45 rose 11 percent from 2012 to 2022.
The $15 million grant was awarded in September 2026.
The Big Picture
This grant updates the research priorities established following the 1993 founding of the Breast Cancer Research Foundation. The investment marks a targeted pivot to address the specific clinical needs of younger women in the oncology field.
The initiative aims to improve early detection and risk prediction for younger women who are currently facing higher rates of aggressive diagnoses. Patients may benefit from future advancements in preventative screening and tailored treatment protocols as the research matures.
The takeaway
Breast cancer in younger patients is often discovered at later stages due to different risk profiles and biological aggressiveness. Increased awareness and targeted clinical research are essential to closing the diagnostic gap for women under 45.
Further reading
Learn more about the latest research and clinical developments at the Cancer hub.
Live Poll
Should medical research funding be more heavily prioritized for younger women at risk for breast cancer?
